249
Views
6
CrossRef citations to date
0
Altmetric
CASE REPORT

Sulbutiamine, an ‘innocent’ over the counter drug, interferes with therapeutic outcome of bipolar disorder

, & , FICPM , MD , PhD
Pages 183-185 | Received 14 Jul 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hayam M. Lotfy, Mohamed A. Abdallah & Medhat A. Al-Ghobashy. (2016) Development and Validation of Stability Indicating Spectrophotometric Methods for Determination of Sulbutiamine in Tablet Dosage Form. Analytical Chemistry Letters 6:2, pages 159-173.
Read now

Articles from other publishers (5)

Jaeah Kim, Christopher P. Hopper, Kelsey H. Connell, Parisa Darkhal, Jason A. Zastre & Michael G. Bartlett. (2016) Development of a novel method for the bioanalysis of benfotiamine and sulbutiamine in cancer cells. Analytical Methods 8:28, pages 5596-5603.
Crossref
Jessica Harder, Samata Sharma & David Gitlin. (2014) Secondary Mania as a Possible Neuropsychiatric Complication of Dengue Fever. Psychosomatics 55:5, pages 512-516.
Crossref
Kui Dong Kang, Aman Shah Abdul Majid, Kyung-A Kim, Kyungsu Kang, Hong Ryul Ahn, Chu Won Nho & Sang Hoon Jung. (2010) Sulbutiamine Counteracts Trophic Factor Deprivation Induced Apoptotic Cell Death in Transformed Retinal Ganglion Cells. Neurochemical Research 35:11, pages 1828-1839.
Crossref
Tim Sobolevsky & Grigory Rodchenkov. (2010) Sulbutiamine in sports. Drug Testing and Analysis 2:11-12, pages 643-646.
Crossref
Marie-Laure Volvert, Sandrine Seyen, Marie Piette, Brigitte Evrard, Marjorie Gangolf, Jean-Christophe Plumier & Lucien Bettendorff. (2008) Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacology 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.